These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 34805183)

  • 21. A novel identified pyroptosis-related prognostic signature of colorectal cancer.
    Zheng C; Tan Z
    Math Biosci Eng; 2021 Oct; 18(6):8783-8796. PubMed ID: 34814322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
    Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
    World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
    Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
    Front Oncol; 2022; 12():904464. PubMed ID: 35912258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia-related tumor environment correlated with immune infiltration and therapeutic sensitivity in diffuse large B-cell lymphoma.
    Liu C; Liu L
    Front Genet; 2022; 13():1037716. PubMed ID: 36313435
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients.
    Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J
    Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer.
    Wu T; Li S; Yu C; Wu Y; Long H
    Sci Rep; 2022 Dec; 12(1):21467. PubMed ID: 36509838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma.
    Gong Z; Li Q; Yang J; Zhang P; Sun W; Ren Q; Tang J; Wang W; Gong H; Li J
    Front Bioeng Biotechnol; 2022; 10():852734. PubMed ID: 35646872
    [No Abstract]   [Full Text] [Related]  

  • 28. An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy.
    Hu J; Xu J; Yu M; Gao Y; Liu R; Zhou H; Zhang W
    J Transl Med; 2020 Mar; 18(1):144. PubMed ID: 32228625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of lactate regulation pattern on tumor immune infiltration, therapy response, and DNA methylation in diffuse large B-cell lymphoma.
    Wang J; Wang Y; Wan L; Chen X; Zhang H; Yang S; Zhong L
    Front Immunol; 2023; 14():1230017. PubMed ID: 37790933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
    Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
    Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two Pyroptosis-Related Subtypes with Distinct Immune Microenvironment Characteristics and a Novel Signature for Predicting Immunotherapy Response and Prognosis in Uveal Melanoma.
    Lei S; Li H
    Curr Eye Res; 2022 Jun; 47(6):930-943. PubMed ID: 35348009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
    Ping L; Zhang K; Ou X; Qiu X; Xiao X
    Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
    [No Abstract]   [Full Text] [Related]  

  • 33. A pyroptosis-related signature in colorectal cancer: exploring its prognostic value and immunological characteristics.
    Jiang P; Fan J; Huang S; Liu L; Bai M; Sun Q; Shen J; Zhang N; Liu D; Zhou N; Feng Y; Jiang J; Zhu J
    PeerJ; 2023; 11():e16631. PubMed ID: 38144182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Pyroptosis-Related Risk Genes APOBEC3D, TNFRSF14, and RAC2 Were Used to Evaluate Prognosis and as Tumor Suppressor Genes in Breast Cancer.
    Chen Q; Jun H; Yang C; Yang F; Xu Y
    J Oncol; 2022; 2022():3625790. PubMed ID: 36059808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
    Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
    J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes.
    Pan T; He Y; Chen H; Pei J; Li Y; Zeng R; Xia J; Zuo Y; Qin L; Chen S; Xiao L; Zhou H
    Front Oncol; 2021; 11():614211. PubMed ID: 33692952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma.
    Qi L; Xu R; Wan L; Ren X; Zhang W; Zhang K; Tu C; Li Z
    Front Genet; 2021; 12():773373. PubMed ID: 34925457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients.
    Zhao C; Huang R; Zeng Z; Yang S; Lu W; Liu J; Wei Y; Guo H; Zhang Y; Yan P; Huang Z; Shi J
    Aging (Albany NY); 2021 May; 13(10):14131-14158. PubMed ID: 34001679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic, Immunological, and Clinical Characterization of Pyroptosis in Ovarian Cancer.
    Zhou M; Li B; Liu J; Hong L
    J Inflamm Res; 2021; 14():7341-7358. PubMed ID: 34992421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
    Fu XW; Song CQ
    Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.